Hygeia Healthcare Holdings Co., Limited (HKG:6078)
13.76
-0.29 (-2.06%)
Sep 18, 2025, 4:08 PM HKT
HKG:6078 Revenue
Hygeia Healthcare Holdings had revenue of 1.99B CNY in the half year ending June 30, 2025, with 13.08% growth. This brings the company's revenue in the last twelve months to 4.05B, down -13.73% year-over-year. In the year 2024, Hygeia Healthcare Holdings had annual revenue of 4.45B with 9.06% growth.
Revenue (ttm)
4.05B CNY
Revenue Growth
-13.73%
P/S Ratio
1.92
Revenue / Employee
496.25K CNY
Employees
8,169
Market Cap
8.51B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.45B | 369.44M | 9.06% |
Dec 31, 2023 | 4.08B | 881.03M | 27.57% |
Dec 31, 2022 | 3.20B | 880.30M | 38.02% |
Dec 31, 2021 | 2.32B | 913.59M | 65.17% |
Dec 31, 2020 | 1.40B | 315.94M | 29.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |